Literature DB >> 12538708

Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues.

Swen Wagner1, Nicholas J Lynch, Wolfgang Walter, Wilhelm J Schwaeble, Michael Loos.   

Abstract

Mannose-binding lectin (MBL), a member of the collectin family, binds to carbohydrate structures on the surfaces of micro-organisms and may serve as a recognition molecule of the lectin pathway of complement activation. In rodents two forms, MBL-A and MBL-C, were described and shown to be products of two related, but uncoupled, genes. The liver is the main source of MBL biosynthesis. For rat MBL-A, expression has also been described in the kidney. Here we report that the two forms of murine MBL are differentially expressed in a number of nonhepatic tissues. Real-time RT-PCR revealed that the liver is the major site of expression for both MBL genes. Lower copy numbers were found in kidney, brain, spleen, and muscle. In testis, only the MBL-A gene is expressed, whereas MBL-C is exclusively expressed in small intestine. Using in situ hybridization and immunohistochemistry, we demonstrate that both MBLs are synthesized by hepatocytes and show MBL expression in cells of the monocyte/macrophage lineage. In the kidney MBL-A, but not MBL-C, was found to be synthesized. Vice versa, only MBL-C biosynthesis was detected in endothelial cells of the small intestine. The latter finding may support the view that MBL-C, as part of the innate immune system, may be a counterpart of secretory IgA of the acquired immune system in preventing, for example, microbial invasion and colonization. Our findings demonstrate that MBL-A and MBL-C are differentially expressed, implying distinct biological roles for both recognition molecules of the murine lectin pathway of complement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538708     DOI: 10.4049/jimmunol.170.3.1462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  The complement system in schizophrenia.

Authors:  Karine R Mayilyan; Daniel R Weinberger; Robert B Sim
Journal:  Drug News Perspect       Date:  2008-05

2.  Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Authors:  Franca Orsini; Pia Villa; Sara Parrella; Rosalia Zangari; Elisa R Zanier; Raffaella Gesuete; Matteo Stravalaci; Stefano Fumagalli; Roberta Ottria; José J Reina; Alessandra Paladini; Edoardo Micotti; Renato Ribeiro-Viana; Javier Rojo; Vasile I Pavlov; Gregory L Stahl; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Circulation       Date:  2012-08-09       Impact factor: 29.690

3.  The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.

Authors:  Helena Morrison; Jennifer Frye; Grace Davis-Gorman; Janet Funk; Paul McDonagh; Gregory Stahl; Leslie Ritter
Journal:  Curr Neurovasc Res       Date:  2011-02       Impact factor: 1.990

4.  Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.

Authors:  Susanne R Youngren; Rohit Mulik; Byoung Jun; Peter R Hoffmann; Kenneth R Morris; Mahavir B Chougule
Journal:  AAPS PharmSciTech       Date:  2013-09       Impact factor: 3.246

5.  Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.

Authors:  Kumud K Singh; Satyanarayana Nathamu; Anthony Adame; Tara U Alire; Wilmar Dumaop; Ben Gouaux; David J Moore; Eliezer Masliah
Journal:  Neurobehav HIV Med       Date:  2011-05-01

6.  The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury.

Authors:  Bart de Vries; Sarah J Walter; Carine J Peutz-Kootstra; Tim G A M Wolfs; L W Ernest van Heurn; Wim A Buurman
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 7.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

8.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  The human collagen beta(1-O)galactosyltransferase, GLT25D1, is a soluble endoplasmic reticulum localized protein.

Authors:  Jolanda Mp Liefhebber; Simone Punt; Willy Jm Spaan; Hans C van Leeuwen
Journal:  BMC Cell Biol       Date:  2010-05-14       Impact factor: 4.241

10.  A two-nucleotide deletion renders the mannose-binding lectin 2 (MBL2) gene nonfunctional in Danish Landrace and Duroc pigs.

Authors:  I M Bergman; K Edman; P van As; A Huisman; Helle Risdahl Juul-Madsen
Journal:  Immunogenetics       Date:  2014-01-31       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.